ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

EVGN Evogene Ltd

0.6951
-0.0104 (-1.47%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Evogene Ltd EVGN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0104 -1.47% 0.6951 09:00:00
始値 安値 高値 終値 前日終値
0.70 0.6706 0.7315 0.71 0.7055
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1620:00PRNUSBiomica to Present at the American Society of Clinical..
2024/4/1120:00PRNUSBiomica to Present at Digestive Disease Week (DDW)..
2024/4/0220:00PRNUSEvogene and The Kitchen FoodTech Hub by Strauss Group..
2024/3/2822:00PRNUSEvogene Announces Filing of Annual Report on Form 20-F
2024/3/2022:00PRNUSEvogene Reports Receipt of Nasdaq Minimum Bid Price..
2024/3/1922:00PRNUSBayer AG and Lavie Bio Continue for Second Year of..
2024/3/1322:00PRNUSLavie Bio and Ceres Global Ag Corp. Collaborate to Include..
2024/3/0721:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0721:00PRNUSEvogene Reports Fourth Quarter and Full Year 2023 Financial..
2024/3/0621:00PRNUSAgPlenus Achieves Milestone in Collaboration with Corteva to..
2024/3/0521:00PRNUSCasterra Announces New Agreements with Seed Producers in..
2024/3/0121:03EDGAR2Form F-3 - Registration statement by foreign private issuers
2024/2/2821:00PRNUSLavie Bio Successfully Secures Second Half Advance Payment..
2024/2/2621:00PRNUSEvogene Schedules Fourth Quarter 2023 Financial Results..
2024/2/2221:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2221:00PRNUSAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as..
2024/2/2121:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2121:00PRNUSAgPlenus Announces Licensing & Collaboration Agreement with..
2024/2/2021:00PRNUSSyngenta and Lavie Bio Announce Partnership to Discover and..
2024/2/1510:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0621:08PRNUSEvogene and Verb Biotics Enter Collaboration Agreement to..
2024/1/2321:00PRNUSBiomica CEO Set to Engage in Panel Discussion at 8th Annual..
2024/1/1721:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1721:00PRNUSBiomica Successfully Completes Phase I Trial Enrollment for..
2024/1/0922:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2121:00PRNUSBiomica CEO Set to Attend JP Morgan Healthcare Week in San..
2023/12/1921:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1921:00PRNUSCasterra Appoints New CEO and Expands Team to Drive Growth..
2023/12/0521:00PRNUSLavie Bio Announces a Distribution Agreement with WinField..
2023/11/2821:00PRNUSLavie Bio Announces Expansion of its Bio-Inoculant Product..
2023/11/1521:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1521:00PRNUSEvogene Reports Third Quarter 2023 Financial Results
2023/11/0821:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0220:00PRNUSEvogene Schedules Third Quarter 2023 Financial Results..
2023/10/3120:00PRNUSColors Farm, Evogene and Ben-Gurion University Collaborate..
2023/10/1820:00PRNUSEvogene Provides Operational Update Amidst Current Security..
2023/9/2720:00PRNUSCasterra Delivers First Shipment of Castor Seeds to Africa
2023/9/2120:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1920:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1720:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1720:00PRNUSEvogene Reports Second Quarter 2023 Financial Results
2023/8/1520:00PRNUSBiomica Opens Second Site to Advance Its Immuno-Oncology..
2023/8/0820:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0120:00PRNUSEvogene Schedules Second Quarter 2023 Financial Results..
2023/7/2520:00PRNUSEvogene's ChemPass AI Tech-Engine is Introduced with New..
2023/7/1920:00PRNUSBiomica Announces Interim Positive Results from Pre-Clinical..
2023/7/1903:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/1721:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄

Delayed Upgrade Clock